LUMA Vision Wins FDA Clearance for VERAFEYE Cardiac Platform
Dublin, Ireland, September 9, 2026 LUMA Vision has secured additional U.S. FDA clearance for its VERAFEYE™ procedural intelligence platform,...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
Dublin, Ireland, September 9, 2026 LUMA Vision has secured additional U.S. FDA clearance for its VERAFEYE™ procedural intelligence platform,...
Cambridge, Massachusetts, USA, September 8, 2026 LabCentral has launched The Loop, a new program designed to help international biotech...
